Alzheimer's Disease Research

Alzheimer's disease (AD), the most common type of dementia, is an irreversible and progressive neurodegenerative disorder causing cognitive and functional impairment. It is characterized by formation of protein aggregates and progressive loss of neurons in the central nervous system (CNS). The symptoms of AD include short-term memory loss, confusion, irritability, aggression and mood swings, progressing to long-term memory deficit, withdrawal from social interactions and subsequently a loss in higher central functioning.

Alzheimer's Disease Research Products Targets

Products for Alzheimer's Disease Research - Page 37

  1. Cat.No. Product Name Information/Activity
  2. BCC6688 Ifenprodil hemitartrate 23210-56-2 Ifenprodil hemitartrate chemical structure
  3. BCC7508 threo Ifenprodil hemitartrate 1312991-83-5 threo Ifenprodil hemitartrate chemical structure
  4. BCC5982 Ketamine hydrochloride 1867-66-9 Ketamine hydrochloride chemical structure
  5. BCC7930 (S)-(+)-Ketamine hydrochloride 33643-47-9 (S)-(+)-Ketamine hydrochloride chemical structure
  6. BCC6774 L-689,560 L-689560 is a potent N-methyl-D-aspartate (NMDA) receptor antagonist at the GluN1 glycine binding site. L-689560 is widely used as a radiolabeled ligand in binding studies and used for study the roles of NMDA receptors in normal neurological processes as well as in diseases. L-689,560 chemical structure
  7. BCC6755 L-701,252 151057-13-5 L-701,252 chemical structure
  8. BCC6842 L-701,324 L-701324 is an orally active and long acting anticonvulsant with high affinity and selectivity for the glycine site on the NMDA receptor. L-701,324 chemical structure
  9. BCC4380 Loperamide HCl Loperamide (hydrochloride) (R-18553 (hydrochloride)) is an opioid receptor agonist. Loperamide hydrochloride is a selective and competitive Loperamide HCl chemical structure
  10. BCC5771 LY 233053 125546-04-5 LY 233053 chemical structure
  11. BCC6892 LY 235959 137433-06-8 LY 235959 chemical structure

Items 361 to 370 of 399 total